Technical Analysis for CRVS - Corvus Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
F 2.83 3.28% 0.09
CRVS closed up 3.28 percent on Wednesday, April 14, 2021, on 19 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down
Historical CRVS trend table...

Date Alert Name Type % Chg
Bullish Engulfing Bullish 0.00%
Stochastic Buy Signal Bullish 0.00%
Oversold Stochastic Weakness 0.00%
Lower Bollinger Band Walk Weakness 3.28%
Lower Bollinger Band Touch Weakness 3.28%
Oversold Stochastic Weakness 3.28%
MACD Bearish Signal Line Cross Bearish 3.66%
Stochastic Reached Oversold Weakness 3.66%
Below Lower BB Weakness 3.66%
Down 3 Days in a Row Weakness 3.66%
Older End-of-Day Signals for CRVS ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Rose Above Previous Day's High about 16 hours ago
Up 5% about 16 hours ago
Up 3% about 16 hours ago
Up 2% about 16 hours ago
Up 1% about 16 hours ago
View Earlier Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Corvus Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology therapies that are designed to harness the immune system to attack cancer cells. Its lead product candidate is CPI-444, an oral, small molecule antagonist of the A2A receptor that plan to initiate a Phase 1/1b clinical trial for adenosine, an immune checkpoint. The company also develops a product candidate, an anti-CD73 monoclonal antibody that inhibits the production of adenosine. Corvus Pharmaceuticals, Inc. was founded in 2014 and is based in Burlingame, California.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biopharmaceutical Life Sciences Immunology Immune System Monoclonal Antibody Cancer Immunotherapy Cancer Cell Immune Checkpoint Adenosine Cd73 Oncology Therapies

Is CRVS a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 6.88
52 Week Low 2.12
Average Volume 1,067,778
200-Day Moving Average 3.83
50-Day Moving Average 3.38
20-Day Moving Average 3.01
10-Day Moving Average 2.95
Average True Range 0.20
ADX 17.86
+DI 16.35
-DI 26.91
Chandelier Exit (Long, 3 ATRs ) 2.88
Chandelier Exit (Short, 3 ATRs ) 3.27
Upper Bollinger Band 3.33
Lower Bollinger Band 2.70
Percent B (%b) 0.21
BandWidth 20.77
MACD Line -0.14
MACD Signal Line -0.14
MACD Histogram -0.0065
Fundamentals Value
Market Cap 79.34 Million
Num Shares 28 Million
EPS -1.56
Price-to-Earnings (P/E) Ratio -1.82
Price-to-Sales 0.00
Price-to-Book 2.64
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.06
Resistance 3 (R3) 3.05 2.97 3.02
Resistance 2 (R2) 2.97 2.91 2.97 3.00
Resistance 1 (R1) 2.90 2.88 2.94 2.91 2.99
Pivot Point 2.82 2.82 2.84 2.82 2.82
Support 1 (S1) 2.75 2.76 2.79 2.76 2.67
Support 2 (S2) 2.67 2.73 2.67 2.66
Support 3 (S3) 2.60 2.67 2.64
Support 4 (S4) 2.61